Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis

Table 3

Spearman correlations of IGFBPs with cutaneous manifestations assessed by cutaneous assessment tool.

Characteristics	Sample size	IGFBP1		IGFBP2		IGFBP3		IGFBP4		IGFBP6		CTGF
			value		value		value		value		value		value
Skin disease activity	64	0.588	<0.001	0.396	0.001	-0.294	0.018	0.232	0.065	0.240	0.056	0.325	0.009
Skin disease damage	64	0.551	<0.001	0.348	0.005	-0.324	0.009	0.178	0.159	0.219	0.082	0.283	0.024

Bold fonts indicate statistical significance.